Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Argentina molecular diagnostics market was valued at USD 932.79 Million in 2025 and is expected to grow at a CAGR of 7.70%, reaching USD 1958.58 Million by 2035. The market continues to benefit from rising demand for personalized healthcare and earlier disease identification. The adoption of advanced sequencing technologies, automated laboratory systems, and point-of-care molecular testing is expected to expand diagnostic capabilities and support sustained market growth as healthcare providers increasingly prioritize accurate and timely testing.
Compound Annual Growth Rate
7.7%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Molecular diagnostics continues to increase as healthcare systems place greater emphasis on precise diagnosis and evidence-based treatment decisions. Molecular testing is being applied across areas such as infectious diseases, cancer diagnosis, genetic testing, and disease monitoring. The market is benefiting from the increasing need for sophisticated diagnostic technologies and more efficient testing processes. Expansion of healthcare services, greater awareness of molecular testing, and ongoing technological innovation are supporting market development. The adoption of advanced diagnostic platforms across hospitals, laboratories, and other healthcare facilities is further strengthening the role of molecular diagnostics within the country. The market is poised to reach USD 1958.58 Million by 2035.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising cancer burden increases demand for accurate molecular testing and genetic profiling to support diagnosis and personalized treatment selection. |
The OECD projects cancer will account for 18% of premature deaths in Argentina between 2023 and 2050. |
|
Market Restraints |
High testing costs and unequal access to specialized laboratories limit molecular diagnostic adoption, particularly in smaller facilities and underserved regions. |
Smaller healthcare facilities may struggle to afford advanced instruments, reagents, and laboratory infrastructure, restricting access to molecular diagnostic services. |
|
Market Opportunities |
Expanding local operations, technical support, and disease-specific testing create opportunities to improve diagnostic product distribution and market access. |
In April 2024, Altona Diagnostics appointed new leadership for its Argentine subsidiary, supporting development and demand for infectious disease testing products. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Rising Cancer Burden is Likely to Strengthen the Market Landscape
The increasing burden of cancer is supporting demand for molecular diagnostics in Argentina, as accurate disease detection and molecular profiling are important for diagnosis and treatment selection. Molecular diagnostic technologies can identify genetic alterations associated with different cancers and help guide personalized treatment decisions. According to the Organization for Economic Co-operation and Development (OECD), cancer is the third-leading cause of mortality in Argentina, with cancer expected to account for 18% of premature deaths between 2023 and 2050. This substantial disease burden is likely to support demand for advanced molecular diagnostic testing.
High Testing Costs and Unequal Access May Limit Market Expansion
The high costs of molecular diagnostic instruments, reagents, and specialized laboratory infrastructure can limit adoption across Argentina. Smaller healthcare facilities and laboratories may face financial constraints when investing in advanced testing technologies, while differences in access to specialized facilities can delay the availability of molecular testing outside major urban centers. These challenges may restrict routine testing, limit access for some patient groups, and slow the expansion of molecular diagnostic services across the country.
Growing Need for Early and Accurate Infectious Disease Diagnosis to Elevate the Market Growth
The increasing risk of infectious disease outbreaks across Argentina and the Americas is expected to support demand for molecular diagnostic testing. According to the Pan American Health Organization and World Health Organization, in May 2025, yellow fever cases increased substantially across the region, highlighting the importance of early detection and laboratory confirmation. The need for timely identification of viral pathogens is likely to encourage the adoption of molecular diagnostic technologies, including polymerase chain reaction (PCR) testing, in Argentina.
The market is witnessing trends such as strengthened local operations and increased demand for disease-specific molecular diagnostic testing for infectious and emerging diseases.
Expanding Local Operations and Disease-Specific Testing Is Likely to Boost Market Value
The market is increasingly focusing on local operations, and strengthening customer relationships can elevate the market for molecular diagnostic providers in Argentina. Greater investment in sales, technical support, and diagnostic product distribution can improve access to specialized tests for infectious and emerging diseases. For instance, in April 2024, Altona Diagnostics announced new leadership for its Argentine subsidiary to support its continued development. The company reported demand for products targeting respiratory diseases, dengue, chikungunya, and Chagas disease, supporting further market expansion.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Infectious Diseases Segment Is Positioned to Maintain Strong Market by Application
The market is segmented by application into oncology, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, and others. Among these, infectious diseases may represent a leading application because molecular diagnostic tests support the detection of pathogens responsible for respiratory infections and emerging diseases. According to the Pan American Health Organization (PAHO), Argentina recorded 27 new tuberculosis cases per 100,000 people in 2022, while the estimated HIV incidence rate was 11.7 per 100,000 people. This disease burden supports continued demand for molecular testing and is likely to contribute to segment expansion.
The key features of the market report include funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
CEPHEID INC. develops molecular diagnostic solutions for clinical testing, with its GeneXpert® systems serving as a key component of its portfolio. These systems support polymerase chain reaction (PCR) testing across various healthcare settings, delivering laboratory-quality results with simplified workflows. The company contributes to the market through its molecular testing technologies and expanding diagnostic capabilities.
EIKEN CHEMICAL CO., LTD is a healthcare company focused on protecting global health through diagnostic solutions and research. Its corporate priorities emphasize improving access to medical services, advancing healthcare technologies, and addressing public health challenges. The company is involved in the market through its broader diagnostic expertise and commitment to supporting accessible healthcare, although the provided information does not specify Argentina-specific products.
QIAGEN N.V. provides molecular diagnostic and sample-processing technologies, including the QIAsymphony Connect system for automated nucleic acid purification. The platform processes up to 96 samples and supports clinical diagnostic and research workflows. Its automated extraction, sample traceability, and compatibility with sensitive downstream applications, including PCR and next-generation sequencing, support the company's involvement in the Argentina molecular diagnostics market.
Hologic, Inc. develops molecular diagnostic solutions for women's health, including the Aptima® HPV Assay and Aptima® HPV 16 18/45 Genotype Assay. These mRNA-based tests detect high-risk human papillomavirus infections and identify clinically important genotypes associated with cervical cancer. Hologic contributes to the market through its molecular testing portfolio and cervical cancer screening technologies.
Other key players in the market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., ILLUMINA, INC, BioMérieux SA, and Sysmex Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product and Services
In Argentina, the product and services structure of the market reflects the solutions supporting diagnostic testing from laboratory preparation through result generation. The growing testing activity, healthcare modernization, and continued improvements in molecular diagnostic capabilities are contributing to market expansion.
Market Breakup by Test Location
The distribution of molecular diagnostic testing across different locations forms an important part of the market. Greater focus on accessible healthcare, rapid results, patient-centered services, and flexible diagnostic delivery is influencing where molecular testing is increasingly performed.
Market Breakup by Technology
Technological segmentation covers the molecular diagnostic approaches available for identifying and analyzing biological targets in Argentina. Research and development, enhanced diagnostic performance, process automation, and improvements in testing efficiency are supporting the deployment of increasingly advanced molecular diagnostic technologies.
Market Breakup by Application
Molecular diagnostics serve a range of diagnostic and clinical requirements in Argentina, supporting the identification and management of various diseases. Expanding healthcare needs, increasing diagnostic precision, and growing integration of molecular information into treatment decisions are supporting demand across application segments.
Market Breakup by End User
The end-user landscape encompasses the healthcare and laboratory organizations utilizing molecular diagnostic solutions. Increasing patient testing needs, expansion of diagnostic infrastructure, and wider adoption of molecular testing within healthcare delivery are contributing to continued market development.
This report is developed through a robust mixed-methods research design combining:
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Test Location |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.